August 10, 2022
Researchers with the Ohio State University Wexner Medical Center are finding out more about the link between chronic pain and opioid use disorders.
July 26, 2022
The nation’s per capita supply of methadone fell 20% from the first quarter of 2020 to the second quarter of that year, according to a new analysis.
July 12, 2022
An Ohio State researcher discusses a new medical center education program for navigating addiction risk in pain patients.
July 12, 2022
Central sensitization may be an important underlying factor that complicates the treatment of chronic pain and opioid use disorders, researchers wrote in PAIN Reports.
July 11, 2022
This first-of-its-kind study by researchers at The Ohio State University Wexner Medical Center and College of Medicine and University of Michigan Medical School explored one potential mechanism – central sensitization – among individuals with OUD.
July 6, 2022
Survey findings raise new concern about access to reproductive health care, including abortion
July 5, 2022
What You Need To Know: Rep. Mike Turner announced details of the Mainstream Addiction and Treatment Act. It's a bill that would allow practitioners to prescribe Buprenorphine without a waiver from the Drug Enforcement Administration. Buprenorphine is a prescription drug that helps treat pain and addiction to opioids. The bill has been passed by the House of Representatives and waiting to be voted on by the Senate